How Do European Issuers Reach US Investors With Programmable Assets?

In brief: Issuant is partnering with Brickken to give institutions a clear, compliant route into the US market. Issuant brings the broker-dealer and registered investment adviser framework needed to place an instrument with US investors, while Brickken brings the infrastructure to issue and operate it. Together, the partnership consolidates capabilities that issuers have historically had to source, assess, and implement separately.

Reaching US investors with a programmable, real-world asset takes two distinct competencies that rarely sit under one roof: the ability to structure and operate the instrument, and the ability to clear the regulatory bar to distribute it. The Issuant and Brickken partnership brings both together under a single engagement. Issuant supplies the regulatory side, broker-dealer and registered investment adviser capability held in-house rather than outsourced. Brickken supplies the issuance engine, compliance execution, investor onboarding, and lifecycle management that run across private credit, debt instruments, fund units, equity, and commodities.

The timing matters. The market for tokenized real-world assets reached roughly $24 billion by mid-2025, up 380% over three years according to CoinDesk, and climbed past $35 billion by the end of November 2025 on RWA.xyz data. As institutional capital moves into the category, the gap between building a compliant instrument and actually distributing it becomes the constraint that decides who reaches US allocators.

What problem does this partnership solve?

A compliant instrument still needs a legal path to US investors before it can reach them. Getting there requires two separate skill sets: structuring the asset itself, and clearing the regulatory bar to distribute it. Most providers in this space are built for one or the other, not both.

The distinction is not cosmetic. A registered investment adviser and a broker-dealer are regulated under different statutes and serve different functions: the adviser owes a fiduciary duty and manages assets, while the broker-dealer transacts in securities and is supervised through FINRA. Placing a programmable security with US investors touches both. That regulatory perimeter is exactly why leading issuance platforms have been building toward it. In July 2026, Securitize registered with the SEC as a full investment adviser, adding a licensed function to a stack that already issues digital securities, and Prometheum has expanded its own SEC-registered broker-dealer and transfer agent infrastructure to close the same gap.

The Issuant and Brickken partnership addresses both sides in one engagement. Issuant contributes the regulatory layer: broker-dealer and registered investment adviser capability, held in-house rather than outsourced. Brickken contributes the operating layer, an institutional-grade platform to issue, manage, and operate programmable instruments across asset classes, delivered through Issuer Studio for direct access, White Label Infrastructure for branded deployment, and the Brickken API for embedded workflows.

Why does this gap exist in the first place?

An issuer that solves only the technical side ends up with an instrument it has no legal way to distribute in the US. One that solves only the regulatory side has a compliant path to market and nothing to issue on. Historically, closing that gap has meant running two vendor searches, two diligence processes, and reconciling two implementation timelines, work that falls on the client by default.

The reason is structural. Issuance technology and regulated distribution grew up as separate businesses, with separate cost bases and separate approvals. Brickken has been explicit that it is the technology provider and not the issuer, supplying the compliant infrastructure while the regulated functions sit elsewhere. That division is efficient for the platform, but it leaves the issuer to assemble the missing regulatory pieces itself. Prometheum has argued the same point from the other direction, that the real missing link for scaling programmable securities is distribution, not technology. Pairing a licensed distributor with an issuance platform is how that missing link gets supplied.

Who does this partnership serve?

The engagement is built for two groups whose needs mirror each other across the Atlantic.

For a European issuer, standing up US broker-dealer and adviser capability for one market rarely justifies the cost or the calendar. For a US client, coordinating an infrastructure vendor and a regulatory partner across two contracts introduces exactly the friction that slows a launch. Consolidating both under one engagement removes that overhead on either side.

What comes next?

On 3 September at 15:00 UTC, Issuant CEO Juan Mari will be joined by Brickken's Head of Business Development, Rodrigo Palacios, for a conversation on what it takes to bring programmable capital into the US market.

The discussion will cover how Issuant's regulatory framework and Brickken's infrastructure fit together, what opening the US market means operationally for institutional clients, and how clients can use programmable issuance to move into the US market.

Frequently asked questions

Why do issuers need both a broker-dealer and an issuance platform to reach US investors? Because structuring a compliant instrument and legally distributing it are governed separately. An issuance platform builds and operates the asset, while a broker-dealer or registered investment adviser provides the regulated path to place it with US investors. Neither function substitutes for the other.

What can be issued through this partnership? Brickken's platform supports programmable financial instruments across private credit, debt, funds, equity, and real-world-asset-backed instruments, delivered through Issuer Studio, White Label Infrastructure, and the Brickken API within confirmed scope.

Is programmable issuance a large enough market to justify US entry? The evidence points that way. Independent trackers put the category at over $35 billion by late 2025, with institutional participation rising through the year. For issuers weighing US distribution, that is a market worth reaching through a single compliant route rather than a fragmented one, which is the route Issuant and Brickken have set out to provide.